ZA864396B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
ZA864396B
ZA864396B ZA864396A ZA864396A ZA864396B ZA 864396 B ZA864396 B ZA 864396B ZA 864396 A ZA864396 A ZA 864396A ZA 864396 A ZA864396 A ZA 864396A ZA 864396 B ZA864396 B ZA 864396B
Authority
ZA
South Africa
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
ZA864396A
Other languages
English (en)
Inventor
Roy Victor Davies
James Fraser
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA864396B publication Critical patent/ZA864396B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA864396A 1985-06-15 1986-06-12 Therapeutic agents ZA864396B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515207A GB8515207D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA864396B true ZA864396B (en) 1987-08-26

Family

ID=10580803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864396A ZA864396B (en) 1985-06-15 1986-06-12 Therapeutic agents

Country Status (20)

Country Link
US (1) US4710506A (xx)
EP (1) EP0209977A3 (xx)
JP (1) JPS6236382A (xx)
KR (1) KR870000339A (xx)
AU (1) AU581595B2 (xx)
CS (1) CS258483B2 (xx)
DD (1) DD253823A5 (xx)
DK (1) DK272486A (xx)
ES (1) ES8707243A1 (xx)
FI (1) FI862520A (xx)
GB (1) GB8515207D0 (xx)
GR (1) GR861527B (xx)
HU (1) HU195661B (xx)
JO (1) JO1482B1 (xx)
NO (1) NO862373L (xx)
PH (1) PH22293A (xx)
PL (1) PL266392A1 (xx)
PT (1) PT82759B (xx)
YU (2) YU99386A (xx)
ZA (1) ZA864396B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US6995171B2 (en) * 2001-06-21 2006-02-07 Agouron Pharmaceuticals, Inc. Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
CN100413861C (zh) * 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
US7994192B2 (en) * 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US7973050B2 (en) * 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
ES2392897T3 (es) * 2006-09-26 2012-12-14 Crestone, Inc. Compuestos tienopiridona sustituidos con actividad antibacteriana
EP2559692A1 (en) 2006-11-15 2013-02-20 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of Flavivirus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997545A (en) * 1973-07-23 1976-12-14 Takeda Chemical Industries, Ltd. Thienopyridine-carboxylic acid derivatives
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS5742690A (en) * 1980-08-28 1982-03-10 Kanebo Ltd Thieno 3,2-b pyridinecarboxylic acid derivative
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CS436286A2 (en) 1987-12-17
DK272486D0 (da) 1986-06-10
JPS6236382A (ja) 1987-02-17
EP0209977A2 (en) 1987-01-28
HUT42775A (en) 1987-08-28
ES8707243A1 (es) 1987-07-16
GB8515207D0 (en) 1985-07-17
CS258483B2 (en) 1988-08-16
NO862373L (no) 1986-12-16
FI862520A0 (fi) 1986-06-12
NO862373D0 (no) 1986-06-13
EP0209977A3 (en) 1988-06-08
HU195661B (en) 1988-06-28
AU581595B2 (en) 1989-02-23
DD253823A5 (de) 1988-02-03
FI862520A (fi) 1986-12-16
US4710506A (en) 1987-12-01
PL266392A1 (en) 1988-02-18
GR861527B (en) 1986-10-14
KR870000339A (ko) 1987-02-17
YU99386A (en) 1988-04-30
AU5838386A (en) 1986-12-18
JO1482B1 (en) 1988-03-10
YU121187A (en) 1988-04-30
PT82759A (en) 1986-07-01
PH22293A (en) 1988-07-22
DK272486A (da) 1986-12-16
ES556026A0 (es) 1987-07-16
PT82759B (en) 1988-05-12

Similar Documents

Publication Publication Date Title
GB2188234B (en) Therapeutic agents
GB8515207D0 (en) Therapeutic agents
GB8627484D0 (en) Dementia-improving & therapeutic agents
ZA864288B (en) Therapeutic agents
GB8417194D0 (en) Therapeutic agents
GB8414518D0 (en) Therapeutic agents
GB8629568D0 (en) Therapeutic agent
GB8401288D0 (en) Therapeutic agents
GB8626296D0 (en) Therapeutic agents
GB8529885D0 (en) Therapeutic agent
GB8515208D0 (en) Therapeutic agents
GB8503627D0 (en) Therapeutic agents
GB8503626D0 (en) Therapeutic agents
GB8503624D0 (en) Therapeutic agents
GB8514634D0 (en) Therapeutic agents
GB8524806D0 (en) Therapeutic agents
GB8503625D0 (en) Therapeutic agents
GB8503623D0 (en) Therapeutic agents
GB8420689D0 (en) Therapeutic agents
GB8415386D0 (en) Therapeutic agents
GB8502604D0 (en) Therapeutic agent
GB8504189D0 (en) Therapeutic agent
GB8501707D0 (en) Therapy
ZM984A1 (en) Therapeutic agents
GB8400354D0 (en) Therapeutic agents